Clinical trial for Sickle Cell Disease
Official title Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
ClinicalTrials.gov ID: NCT06919224
What this study is testing
- What it's testing
- The study will see if the app plus booklets lower hospital and ER visits and save money compared to booklets alone.
- Who it's for
- Adults who have sickle cell disease.
- What's involved
- Participants will use a mobile app that shows disease‑specific guidelines and receive printed booklets. They will be followed in a randomized trial and may share feedback on the app’s use.
- Time commitment
- The study lasts about 12 months and includes regular clinic visits and phone check‑ins to track health use and app usage.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- for adults with SCD include
- receiving care at the SCD clinic for the prior 12 months,
- has a diagnosis of SCD (Hgb SS, SC, Sβ-thal),
- able to speak and understand written English,
- older than 18 years. for the providers and staff members are (1) to be involved in participants' clinical care
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
- St Louis, Missouri, United States
- Columbus, Ohio, United States
- Nashville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States; St Louis, Missouri, United States; Columbus, Ohio, United States; Nashville, Tennessee, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.